CPhI Biopharma News

Oct 16, 2018
By BioPharm International Editors
According to CPhI’s annual report, the therapeutic antibody drug conjugates (ADC) market is expected to reach $4 billion by 2023.
Oct 15, 2018
By BioPharm International Editors
The company was awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.
Sep 28, 2018
By BioPharm International Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 28, 2018
By BioPharm International Editors
As Europe and the United Kingdom are facing the ever-expanding shadow of Brexit, a keynote session taking place at CPhI Worldwide in Madrid will look to assess the wider implications of the UK’s exit from the European Union on the Pharma sector.
Sep 28, 2018
By BioPharm International Editors
Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.
Sep 27, 2018
By BioPharm International Editors
The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.
Sep 25, 2018
By BioPharm International Editors
Winners for each category will be revealed at the CPhI Pharma Awards Gala, taking place on Oct. 9, 2018.
Sep 20, 2018
By BioPharm International Editors
The company will be presenting at CPhI Worldwide on Oct. 11, 2018.
Sep 17, 2018
By BioPharm International Editors
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
Sep 17, 2018
By BioPharm International Editors
In the second half of CPhI’s annual report, experts review industry trends and warn that trade and patent changes could increase healthcare cost by $100 billion over the next five years.
native1_300x100
lorem ipsum